Wednesday, August 23, 2017

Kite Pharma - Chart of the Day

Kite Pharma (KITE) is the Barchart Chart of the Day.  The biopharmaceutical company has a Trend Spotter buy signal, a Weighted Alpha of 149.29+ and gained 129.02% in the last year.

The Chart of the Day belongs to Kite Pharma (KITE).  I found the biopharmaceutical stock by using Barchart to sort today's All Time High list first for the highest Weighted Alpha, then again for technical buy signal of 80% or more.  Since the Trend Spotter signaled a buy on 6/8 the stock gained 55.42%.

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc. is headquartered in Santa Monica, California.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 26.59% in the last month
  • Relative Strength Index 82.23%
  • Technical support level at 133.78
  • Recently traded at 138.17 with a 50 day moving average of 108.98
Fundamental factors:
  • Market Cap $7.69 billion
  • Revenue expected to grow 91.80% this year an another 361.30% next year
  • Earnings estimated to increase 13.80% next year
  • Wall Street analysts issued 5 strong buy, 1 buy, 4 hold and 1 sell recommendation on the stock



No comments:

Post a Comment